In Stockholm, Sweden you will get free parking and free congestion charge when your car runs on biofuels. There are 800 service stations in Sweden providing biofuels and more starting to do so every year.

Maybe that’s the reason to why Volvo-cars are seen lined up on the streets, or perhaps, people have been fed up with the highest petrol prices in Europe.

Continue reading “Swedes drive Europe’s biofuel usage” »

According to Fuld & Company, a Boston-based competitive intelligence (CI) consultancy, the USA’s top companies are likely to raise their budgets on information gathering and analysing over the next five years. Fuld’s predictions are based on data from the recent Global Benchmark Study of 141 corporations, which forecasts the amount that the top 1,000 companies will spend on CI will increase from a current $1 billion to at least $10 billion by 2012.

Continue reading “America’s Top Companies to Invest in Competitive Intelligence says Fuld” »

The slow-down in the central nervous system (CNS) drug market growth between 2003 and 2005 is likely to continue over the next three years concludes new market research. CNS Market Trends 2007 to 2010 – Key market forecasts and growth opportunities is forecast to expand to US$63.9 billion in 2010, equivalent to annual growth of just 2.9% .

Continue reading “Slow growth in CNS drug market as patent expiries bite” »

The great British public are following the example of their European cousins and increasingly performing ablutions with naturally manufactured products. Market research from Datamonitor forecasts that the UK for organic personal care products will increase from £9 million in 2007 to £12 million by 2011.

Continue reading “Brits learning to wash naturally: Organic personal care growing” »

Generics could grow to capture 14% of the global healthcare market

A recent report predicts that $100 billion of US and European pharmaceutical company revenues are now threatened by generic drugs.

Continue reading “Why pharmaceutical executives will ask: “Where have all my sales gone?”” »

The pharmaceutical industry is under constant cost-containment pressures in the US, European and Japanese markets, and as it increases its efforts to expand into emerging markets, the MiddleEastern market – worth an estimated $8bn – could prove a strong growth opportunity for those who appreciate its internal dynamics and unique features

Although the Middle East is a promising region for the international pharmaceutical industry, the perceived instability of the region and the different way of conducting business can deter interested firms at first. Local agents are of utmost importance in navigating through the stringent registration and marketing requirements.

Continue reading “Middle East pharma markets could be good growth opportunity” »